Literature DB >> 17204293

The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: implications for cancer, shock, and inflammatory diseases.

Shinobu Furusawa1, Jianghong Wu.   

Abstract

The extract of Stephania cepharantha Hayata contains biscoclaurine alkaloids such as cepharanthine, which have been used widely in Japan for the treatment of patients with radiation-induced leukopenia, alopecia areata, exudative otitis media, and venomous snakebites. Many investigations have proven that the alkaloid cepharanthine exerts diverse pharmacological effects that include membrane-stabilizing, multidrug resistance-reversing, antitumor, apoptosis-inducing, anti-inflammatory, free radical scavenging, anti-HIV-1, antiallergic and immunomodulatory effects. The purpose of our review is to describe various therapeutic approaches using cepharanthine and their potential efficacy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17204293     DOI: 10.1016/j.lfs.2006.12.001

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

1.  Microwave-Assisted Extraction Followed by Solid-Phase Extraction for the Chromatographic Analysis of Alkaloids in Stephania cepharantha.

Authors:  Ying Liu; Daotao Xie; Yun Kang; Yaqin Wang; Ping Yang; Jixian Guo; Jianming Huang
Journal:  J Chromatogr Sci       Date:  2016-01-11       Impact factor: 1.618

2.  Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells.

Authors:  Zan Chen; Chen Huang; Yan-ling Yang; Yi Ding; Han-qiang Ou-Yang; You-yi Zhang; Ming Xu
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

3.  Cepharanthine exerts antitumor activity on choroidal melanoma by reactive oxygen species production and c-Jun N-terminal kinase activation.

Authors:  Qi Zhu; Baofeng Guo; Linlin Chen; Qiuye Ji; Hang Liang; Naiyan Wen; Ling Zhang
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

4.  Cepharanthine Ameliorates Chondrocytic Inflammation and Osteoarthritis via Regulating the MAPK/NF-κB-Autophagy Pathway.

Authors:  Minjun Yao; Caihua Zhang; Lingzhi Ni; Xiaoxiao Ji; Jianqiao Hong; Yazhou Chen; Jie Wang; Congsun Li; Jiyan Lin; Tingting Lu; Yihao Sheng; Menghao Sun; Mingmin Shi; Chenhe Zhou; Xunzi Cai
Journal:  Front Pharmacol       Date:  2022-06-21       Impact factor: 5.988

5.  Biscoclaurine alkaloid cepharanthine protects DNA in TK6 lymphoblastoid cells from constitutive oxidative damage.

Authors:  Dorota Halicka; Masamichi Ita; Toshiki Tanaka; Akira Kurose; Zbigniew Darzynkiewicz
Journal:  Pharmacol Rep       Date:  2008 Jan-Feb       Impact factor: 3.024

6.  Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.

Authors:  Masamichi Ita; H Dorota Halicka; Toshiki Tanaka; Akira Kurose; Barbara Ardelt; Kuslima Shogen; Zbigniew Darzynkiewicz
Journal:  Cancer Biol Ther       Date:  2008-04-19       Impact factor: 4.742

7.  Identification of FDA-approved drugs and bioactives that protect hair cells in the zebrafish (Danio rerio) lateral line and mouse (Mus musculus) utricle.

Authors:  Henry C Ou; Lisa L Cunningham; Shimon P Francis; Carlene S Brandon; Julian A Simon; David W Raible; Edwin W Rubel
Journal:  J Assoc Res Otolaryngol       Date:  2009-02-25

8.  Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo.

Authors:  Han Li; Zhang Yan; Wang Ning; Guo Xiao-Juan; Zang Cai-Hong; Jiang Jin-Hua; Ma Fang; Wang Qing-Duan
Journal:  J Biomed Biotechnol       Date:  2011-06-30

9.  Downregulation of MDR1 gene by cepharanthine hydrochloride is related to the activation of c-Jun/JNK in K562/ADR cells.

Authors:  Li Han; Yafeng Wang; Xiaojuan Guo; Yubing Zhou; Jingmin Zhang; Ning Wang; Jinhua Jiang; Fang Ma; Qingduan Wang
Journal:  Biomed Res Int       Date:  2014-10-16       Impact factor: 3.411

10.  Salutary Effects of Cepharanthine against Skeletal Muscle and Kidney Injuries following Limb Ischemia/Reperfusion.

Authors:  Ming-Chang Kao; Chih-Yang Chung; Ya-Ying Chang; Chih-Kung Lin; Joen-Rong Sheu; Chun-Jen Huang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.